MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-DD-01-0002644
Damao Pharmaceutical Private Limited
Damao Pharmaceutical Private Limited - pharma in Daman, Daman And Diu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹40.14 Lakh
▼ 77% YoY
Net loss · FY 2025
₹29.65 Lakh
Net margin -73.9%
EBITDA · FY 2025
-₹21.94 Lakh
EBITDA margin -54.7%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹2.5 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered
About Damao Pharmaceutical Private Limited
Data last updated:
Damao Pharmaceutical Private Limited is a private limited company based in Daman, Daman And Diu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Goa, under CIN U51909DD2019PTC009846. Its GSTIN is 26AAHCD2027J1ZS (Daman & Diu). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹2.5 Lakh. It is led by directors Urjali Girish Patel and Girishbhai Laxmanbhai Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No.14 – 145/A7 – S1 Airport Road Kathiria, Daman, Daman and Diu, India – 396210.
As per the financials filed for FY 2025, the company reported a revenue of ₹40.14 Lakh, a decline of 77% compared to the previous year. For the same year it recorded a net loss of ₹29.65 Lakh (net margin -73.9%) and EBITDA of -₹21.94 Lakh (EBITDA margin -54.7%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years.
Damao Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DD-01-0002644).
Company Details of Damao Pharmaceutical Private Limited
CIN U51909DD2019PTC009846
Registration Number 009846
Incorporation Date 20 April 2019
ROC Goa
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DD-01-0002644
Recognitions & Rankings of Damao Pharmaceutical
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH. No.14 – 145/A7 – S1 Airport Road Kathiria, Daman, Daman and Diu, India – 396210
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Damao Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Damao Pharmaceutical Private Limited
The main business activity of Damao Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Damao Pharmaceutical Private Limited FY 2025 filings available
Damao Pharmaceutical Private Limited reported revenue of ₹40.14 Lakh (down 77% YoY) for FY 2025.
Revenue · FY 2025
₹40.14 Lakh ▼ 77%
Net loss · FY 2025
₹29.65 Lakh margin -73.9%
EBITDA · FY 2025
-₹21.94 Lakh margin -54.7%
Compounded Annual Growth Rate (CAGR) of Damao Pharmaceutical Private Limited
Revenue CAGR growth
1 year
▼ 77%
3 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▼ 286%
3 years · compounded
▲ 11%
5 years · compounded
▼ 349%
Revenue fell 77% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 10%. EBITDA fell 286% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Damao Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹21.94 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹29.65 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Damao Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -54.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -73.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Damao Pharmaceutical are in the company report.
Premium access
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Damao Pharmaceutical Private Limited
Damao Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Urjali Girish Patel | Director | 13 Sep 2019 | 7 Years 1 Months | Current |
| Girishbhai Laxmanbhai Patel | Director | 20 Apr 2019 | 7 Years 6 Months | Current |
Peer Comparison of Damao Pharmaceutical Private Limited
Damao Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Caresfield Medicines Private Limited | ₹41.67 Lakh (FY 2025) | •••• | •••• | 233.0% | •••• | Rasra, Uttar Pradesh, India |
| Inlabco Biosolutions Private Limited | ₹41.49 Lakh (FY 2024) | •••• | •••• | -10.0% | •••• | Aluva, Kerala, India |
| LN Life Sciences Private Limited | ₹41.18 Lakh (FY 2025) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Vaamveda Healthcare Private Limited | ₹40.96 Lakh (FY 2025) | •••• | •••• | 87.0% | •••• | Bishrakh, Uttar Pradesh, India |
| Concept Laboratories Pvt Ltd | ₹40.42 Lakh (FY 2024) | •••• | •••• | 170.0% | •••• | Mumbai, Maharashtra, India |
| Damao Pharmaceutical Private Limited this company | ₹40.14 Lakh (FY 2025) | •••• | •••• | -77.0% | •••• | Daman, Daman And Diu, India |
| Blazed Pharmaceuticals Private Limited | ₹40.08 Lakh (FY 2025) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Bryos Pharmaceutical Private Limited | ₹40 Lakh (FY 2024) | •••• | •••• | 12.0% | •••• | Dhaniv, Maharashtra, India |
| Medowin India Private Limited | ₹39.69 Lakh (FY 2024) | •••• | •••• | •••• | Chennai, Tamil Nadu, India | |
| Astra Unique Prohealth Private Limited | ₹39.31 Lakh (FY 2025) | •••• | •••• | -21.0% | •••• | Delhi, India |
| Sachkar Pharmaceuticals Private Limited | ₹38.98 Lakh (FY 2025) | •••• | •••• | -1.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Damao Pharmaceutical by revenue in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Damao Pharmaceutical Private Limited
Damao Pharmaceutical Private Limited is audited by B.A DESAI & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| B.A DESAI & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Damao Pharmaceutical Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Damao Pharmaceutical Private Limited
Damao Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
MSME Payment Delays by Damao Pharmaceutical Private Limited
Damao Pharmaceutical Private Limited has 2 MSME Form 1 returns on record between 2022 and 2023, listing 4 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Althea Pharma Private Limited | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Damao Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Damao Pharmaceutical.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Damao Pharmaceutical Private Limited
Damao Pharmaceutical Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Smitesh Girish Patel ceased to be Director on 28 Nov 2025.
Ceased
Smitesh Girish Patel ceased to be Director.
AGM
Damao Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Damao Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Goa.
Ceased
Urjali Girish Patel ceased to be Additional Director.
Appointed
Urjali Girish Patel was appointed as Director.
Appointed
Girishbhai Laxmanbhai Patel was appointed as Director.
Incorporation
20 Apr 2019
Damao Pharmaceutical Private Limited was registered on 20 Apr 2019 with Roc Goa & aged 7 years 6 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Damao Pharmaceutical Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Damao Pharmaceutical Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Damao Pharmaceutical Private Limited
Damao Pharmaceutical has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 26AAHCD2027J1ZS | Daman & Diu | Active | 01 Aug 2020 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Damao Pharmaceutical Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Damao Pharmaceutical Private Limited
Damao Pharmaceutical is an active private limited company based in Daman, Daman And Diu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 April 2019 (7+ years old) and is registered under CIN U51909DD2019PTC009846.
Damao Pharmaceutical reported revenue of ₹40.14 Lakh for FY 2025 (down 77% YoY).
Damao Pharmaceutical has 2 current directors:
- Urjali Girish Patel - Director
- Girishbhai Laxmanbhai Patel - Director
Damao Pharmaceutical reported a net loss of ₹29.65 Lakh (net margin -73.9%) and EBITDA of -₹21.94 Lakh (EBITDA margin -54.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Damao Pharmaceutical is 10% over three years. In the latest year (FY 2025) revenue fell 77%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Damao Pharmaceutical is 26AAHCD2027J1ZS, registered in Daman & Diu. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Damao Pharmaceutical is U51909DD2019PTC009846. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Damao Pharmaceutical was incorporated on 20 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Goa.
The peers of Damao Pharmaceutical by revenue are Caresfield Medicines Private Limited, Inlabco Biosolutions Private Limited, LN Life Sciences Private Limited, Vaamveda Healthcare Private Limited, Concept Laboratories Pvt Ltd and 5 more, all in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations).
Smitesh Girish Patel ceased to be Director on 28 Nov 2025. Urjali Girish Patel ceased to be Additional Director on 04 Oct 2023. Urjali Girish Patel was appointed as Director on 13 Sep 2019. Damao Pharmaceutical has 4 board changes on record in total.
Yes, Damao Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-DD-01-0002644).
Damao Pharmaceutical has 2 MSME Form 1 returns on record between 2022 and 2023, listing 4 overdue payments to 1 micro and small supplier. The latest return was filed on 06 Nov 2023.